未破裂期输卵管妊娠的介入治疗

目的 加强对输卵管妊娠介入治疗中所存在的若干问题的认识。方法 ４０例未破裂输卵管妊娠患者，经阴道输卵管或经子宫动脉两种途径灌注氨甲喋呤治疗，选用Ｒosch-Ｔhurmoud输卵管再通装置，以及４．１～５．０Ｆ导管。超声和尿人绒毛膜促性腺激素（β－hＣＧ）值的变化是监测本组治疗效果的主要指标。结果 １２例接受经阴道输卵管孕囊内注射治疗１５次，其中３例接受２次药物注射；２８例接受子宫动脉内插管治疗。终止妊娠总体成

Interventional treatment of unruptured tubal pregnancy

Objective To discuss some concept about interventional treatment of tubal pregnancy Methods The procedure of transvaginal tubal intra gestational SAC injection (IGSI) or percutaneous intra uteroarterial infusion (IUAI) was selected for treatment of 40 patients with unruptured tubal pregnancy. Methotrexate(MTX), Rosch Thurmoud fallopian tube catheterization set, and the general angiographic catheters of 4 1-5 0 F were uesd for the procedure. Ultrasound and urine beta hCG were the main indexes monitoring the therapeutic effects in this study Results 12 of 40 patients underwent a total of 15 IGSI Of these, 3 patients required a second injection; 28 of 40 cases were treated with IUAI The total successful rate of termination of ectopic pregnancy was 97 5%, the mean resolution time for reduction of beta hCG concentration was 11 7 days (range 4-28), the range of menstruation recovery time was 7-45 days Conclusion The interventional therapy for tubal pregnancy will be more widely applied, on the basis of a better understanding about the pathology, characteristics of embryonic sac development and blood supply, the regular change of concentration of serum and urine hCG in tubal pregnancy